Schwartz PE - Search Results

1

Dual CCNE1/PIK3CA targeting is synergistic in CCNE1-amplified/PIK3CA-mutated uterine serous carcinomas in vitro and in vivo.

Cocco E, Lopez S, Black J, Bellone S, Bonazzoli E, Predolini F, Ferrari F, Schwab CL, Menderes G, Zammataro L, Buza N, Hui P, Wong S, Zhao S, Bai Y, Rimm DL, Ratner E, Litkouhi B, Silasi DA, Azodi M, Schwartz PE, Santin AD. Cocco E, et al. Among authors: schwartz pe. Br J Cancer. 2016 Jul 26;115(3):303-11. doi: 10.1038/bjc.2016.198. Epub 2016 Jun 28. Br J Cancer. 2016. PMID: 27351214 Free PMC article.

2

CA 125 may not reflect disease status in patients with uterine serous carcinoma.

Price FV, Chambers SK, Carcangiu ML, Kohorn EI, Schwartz PE, Chambers JT. Price FV, et al. Among authors: schwartz pe. Cancer. 1998 May 1;82(9):1720-5. doi: 10.1002/(sici)1097-0142(19980501)82:9<1720::aid-cncr19>3.0.co;2-6. Cancer. 1998. PMID: 9576294

3

Serous adenocarcinoma of the uterus presenting as paraneoplastic cerebellar degeneration.

Johns JB, Odunsi KO, Fleischman S, Azodi M, Schwartz PE. Johns JB, et al. Among authors: schwartz pe. Gynecol Oncol. 1999 May;73(2):326-30. doi: 10.1006/gyno.1998.5324. Gynecol Oncol. 1999. PMID: 10329056 Free article.

4

Adenocarcinoma in situ of the cervix: management and outcome.

Azodi M, Chambers SK, Rutherford TJ, Kohorn EI, Schwartz PE, Chambers JT. Azodi M, et al. Among authors: schwartz pe. Gynecol Oncol. 1999 Jun;73(3):348-53. doi: 10.1006/gyno.1999.5395. Gynecol Oncol. 1999. PMID: 10366458 Free article.

5

Minimal uterine serous carcinoma: a clinicopathological study of 40 cases.

Hui P, Kelly M, O'Malley DM, Tavassoli F, Schwartz PE. Hui P, et al. Among authors: schwartz pe. Mod Pathol. 2005 Jan;18(1):75-82. doi: 10.1038/modpathol.3800271. Mod Pathol. 2005. PMID: 15389257 Free article.

6

Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation.

Kelly MG, O'Malley D, Hui P, McAlpine J, Dziura J, Rutherford TJ, Azodi M, Chambers SK, Schwartz PE. Kelly MG, et al. Among authors: schwartz pe. Gynecol Oncol. 2004 Dec;95(3):469-73. doi: 10.1016/j.ygyno.2004.08.030. Gynecol Oncol. 2004. PMID: 15581948

7

Weekly topotecan in heavily pretreated patients with recurrent epithelial ovarian carcinoma.

O'Malley DM, Azodi M, Makkenchery A, Tangir J, McAlpine J, Kelly M, Schwartz P, Rutherford T. O'Malley DM, et al. Gynecol Oncol. 2005 Aug;98(2):242-8. doi: 10.1016/j.ygyno.2005.04.032. Gynecol Oncol. 2005. PMID: 15992916

8

Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy.

Kelly MG, O'malley DM, Hui P, McAlpine J, Yu H, Rutherford TJ, Azodi M, Schwartz PE. Kelly MG, et al. Among authors: schwartz pe. Gynecol Oncol. 2005 Sep;98(3):353-9. doi: 10.1016/j.ygyno.2005.06.012. Gynecol Oncol. 2005. PMID: 16005947

9

Atypical presentations of carboplatin hypersensitivity reactions: characterization and management in patients with gynecologic malignancies.

McAlpine JN, Kelly MG, O'malley DM, Azodi M, Coombe K, Schwartz PE, Rutherford TJ. McAlpine JN, et al. Among authors: schwartz pe. Gynecol Oncol. 2006 Oct;103(1):288-92. doi: 10.1016/j.ygyno.2006.03.007. Epub 2006 May 2. Gynecol Oncol. 2006. PMID: 16647749

10

Carcinosarcoma of the ovary.

Silasi DA, Illuzzi JL, Kelly MG, Rutherford TJ, Mor G, Azodi M, Schwartz PE. Silasi DA, et al. Among authors: schwartz pe. Int J Gynecol Cancer. 2008 Jan-Feb;18(1):22-9. doi: 10.1111/j.1525-1438.2007.00948.x. Epub 2007 Apr 19. Int J Gynecol Cancer. 2008. PMID: 17451459

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

438 results

Search Page

Filters